Appel Pharmaceuticals Acquisition News

Kim Kahn reports Biogen's $5.6B acquisition of Appel's Pharmaceuticals at $41 per share.

Play episode from 01:26

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!